Biotest Aktiengesellschaft (ETR:BIO3)
Germany · Delayed Price · Currency is EUR 28.40
-1.00 (-3.40%)
Jun 6, 2025, 5:10 PM CET
ETR:BIO3 Market Cap
ETR:BIO3 has a market cap or net worth of €1.39 billion as of January 7, 2026.
Market Cap
1.39B
Enterprise Value
2.01B
Revenue
635.20M
Ranking
n/a
PE Ratio
n/a
Stock Price
€28.40
Market Cap Chart
Since January 14, 2025, ETR:BIO3's market cap has increased from 1.08B to 1.39B, an increase of 28.68%. That is a compound annual growth rate of 29.31%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 7, 2026 | 1.39B | 3.24% |
| Dec 30, 2025 | 1.34B | 24.63% |
| Jan 14, 2025 | 1.08B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Merck KGaA | 54.96B |
| Siemens Healthineers AG | 51.44B |
| Bayer Aktiengesellschaft | 37.37B |
| Fresenius SE & Co. KGaA | 27.28B |
| Sartorius Aktiengesellschaft | 16.27B |
| Fresenius Medical Care AG | 11.24B |
| Fielmann Group AG | 3.72B |
| Carl Zeiss Meditec AG | 3.71B |